Clinical Trial Update: Assess Efficacy and Safety of the Dopamine Agonist Pramipexole Versus Levodopa / Benserazide (Madopar® DR) in Patients With Restless Legs Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing pramipexole to Levodopa/Benserazide (Madopar) for restless legs syndrome has completed; the update discusses efficacy and safety asses…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Restless Legs Syndrome

Drugs mentioned

• Madopar (levodopa/benserazide)
• Mirapex (pramipexole)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Restless Legs Syndrome | Phase 3 | Status: COMPLETED